Comparison of the effect of an H3-inverse agonist on energy intake and hypothalamic histamine release in normal mice and leptin resistant mice with high fat diet-induced obesity

Behavioural Brain Research

Volumn 188, Issue 2, 2008, Pages 250-254

  Ishizuka, Tomoko ^a   Hatano, Kouta ^a   Murotani, Tomotaka ^a   Yamatodani, Atsushi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Diet induced obese; Food intake; Leptin; Microdialysis; The histaminergic system

Indexed keywords

CLOBENPROPIT; HISTAMINE; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR INVERSE AGONIST; LEPTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CALORIC INTAKE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HISTAMINE RELEASE; HORMONE RESISTANCE; HYPOTHALAMUS; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; ENERGY INTAKE; FATS; HISTAMINE; HISTAMINE H3 ANTAGONISTS; HYPOTHALAMUS; IMIDAZOLES; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICRODIALYSIS; OBESITY; THIOUREA; TIME FACTORS;

EID: 39149126378     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.11.001     Document Type: Article

References (32)

1. Beck B., Kozak R., Stricker-Krongrad A., and Burlet C. Neuropeptide Y release in the paraventricular nucleus of Long-Evans rats treated with leptin. Biochem Biophys Res Commun 242 (1998) 636-639
2. Brunetti L., Michelotto B., Orlando G., and Vacca M. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. Eur J Pharmacol 372 (1999) 237-240
3. Campfield L.A., Smith F.J., Guisez Y., Devos R., and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546-549
4. Caro J.F., Kolaczynski J.W., Nyce M.R., Ohannesian J.P., Opentanova I., Goldman W.H., et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348 (1996) 159-161
5. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., and Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105 (2000) 1827-1832
6. Garbarg M., Barbin G., Rodergas E., and Schwartz J.C. Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem 35 (1980) 1045-1052
7. Hakansson M.-L., Brown H., Ghilardi N., Skoda R.C., and Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18 (1998) 559-572
8. Hill R.A., Margetic S., Pegg G.G., and Gazzola C. Leptin: its pharmacokinetics and tissue distribution. Int J Obes Relat Metab Disord 124 (1998) 765-770
9. 3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application. Eur J Pharmacol 743 (1996) 149-155
10. 3 agonists on food and water intake and urine flow in Wistar rats. Brain Res 793 (1998) 279-288
11. 3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes (Lond) 29 (2005) 1402-1412
12. Masaki T., Yoshimatsu H., Chiba S., Watanabe T., and Sakata T. Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice. Diabetes 50 (2001) 376-384
13. 1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes 50 (2001) 385-391
14. 125I]iodophenpropit binding. Brain Res 743 (1996) 178-183
15. Mochizuki T., Yamatodani A., Okakura K., Takemura M., Inagaki N., and Wada H. In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis. Naunyn-Schmiedeberg's Arch Pharmacol 343 (1991) 190-195
16. 1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1442-R1448
17. Morimoto T., Yamamoto Y., Mobarakeh J.I., Yanai K., Watanabe T., Watanabe T., et al. Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav 67 (1999) 679-683
18. Morimoto T., Yamamoto Y., and Yamatodani A. Leptin facilitates histamine release from the hypothalamus in rats. Brain Res 868 (2000) 367-369
19. Murotani T., Ishizuka T., Hattori S., Hashimoto R., Matsuzaki S., and Yamatodani A. High dopamine turnover in the brains of Sandy mice. Neurosci Lett 421 (2007) 47-51
20. Orthen-Gambill N. Antihistaminic drugs increase feeding, while histidine suppresses feeding in rats. Pharmacol Biochem Behav 31 (1988) 81-86
21. Orthen-Gambill N., and Salomon M. FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats. Physiol Behav 51 (1992) 891-893
22. Schwartz M.W., Peskind E., Raskind M., Boyko E.J., and Porte Jr. D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2 (1996) 589-593
23. Schwartz M.W., Seeley R.J., Campfield A., Burn P., and Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98 (1996) 1101-1106
24. Sheiner J.B., Morris P., and Anderson G.H. Food intake suppression by histidine. Pharmacol Biochem Behav 23 (1985) 721-726
25. Uehara Y., Shimizu H., Ohtani K., Sato N., and Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 47 (1998) 890-893
26. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99 (1997) 385-390
27. 125I-leptin administration to ob/ob and db/db mice. Horm Metab Res 28 (1996) 653-658
28. Vaziri P., Dang K., and Anderson G.H. Evidence for histamine involvement in the effect of histidine loads on food and water intake in rats. J Nutr 127 (1997) 1519-1526
29. 3 antagonists. J Pharmacol Exp Ther 299 (2001) 908-914
30. Yamatodani A., Fukuda H., Wada H., Iwaeda T., and Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr 344 (1985) 115-123
31. Yoshimatsu H., Itateyama E., Kondou S., Tajima D., Himeno K., Hidaka S., et al. Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 48 (1999) 2286-2291
32. Zhang Y., Proenca R., Maffei M., Barone M., Leopard L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-431